{"gene":"PNKP","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":1999,"finding":"PNKP encodes a bifunctional enzyme with both DNA 5'-kinase and DNA 3'-phosphatase activities. A GST-PNKP fusion protein displayed both activities in vitro, and the 3'-phosphatase domain shows similarity to L-2-haloacid dehalogenases. PNKP expression rescued oxidative-damage sensitivity in E. coli xth nfo double mutants, demonstrating in vivo removal of 3'-phosphate groups to generate termini suitable for DNA polymerase.","method":"GST-fusion protein in vitro kinase/phosphatase assays, E. coli complementation rescue experiment, tryptic peptide sequencing from bovine enzyme","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro enzymatic reconstitution with fusion protein plus in vivo functional complementation, foundational characterization paper","pmids":["10446192"],"is_preprint":false},{"year":2012,"finding":"MCSZ-associated PNKP mutations (L176F, T424Gfs48X, exon15Δfs4X, E326K) reduce or ablate DNA kinase activity in vitro and reduce cellular PNKP protein levels ~10-fold; all mutations result in reduced rates of chromosomal DNA strand break repair in cells. L176F also reduces phosphatase activity, while E326K destabilizes PNKP at physiological temperature.","method":"Recombinant PNKP in vitro kinase and phosphatase assays, Western blotting for cellular protein levels, chromosomal DNA strand break repair assays in patient-derived cells","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple mutants assessed with orthogonal in vitro and cellular assays in a single rigorous study","pmids":["22508754"],"is_preprint":false},{"year":2012,"finding":"ATM phosphorylates PNKP at serines 114 and 126 in response to oxidative DNA damage, inhibiting ubiquitylation-dependent proteasomal degradation of PNKP and increasing its stability. The Cul4A-DDB1 ubiquitin ligase complex (with STRAP as adaptor) is responsible for PNKP ubiquitylation. Strap-/- MEFs have elevated PNKP levels and enhanced resistance to oxidative DNA damage.","method":"Phosphorylation site mapping, ubiquitylation assays, purification of Cul4A-DDB1-STRAP complex, Strap-/- mouse embryonic fibroblast analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — identification of writer kinase (ATM) and E3 ligase complex with multiple orthogonal methods and genetic validation in MEFs","pmids":["23042680"],"is_preprint":false},{"year":2017,"finding":"PNKP forms a stable complex with XRCC4-LigIV in NHEJ. The PNKP FHA domain binds CK2-phosphorylated XRCC4 C-terminal tail; only one PNKP protomer binds per XRCC4 dimer. SAXS reveals a flexible multi-state complex with multipoint contacts between the PNKP FHA and catalytic domains and the XRCC4 coiled-coil/LigIV BRCT repeats. Hydrogen-deuterium exchange identifies a phosphatase domain surface contacting XRCC4-LigIV. The MCSZ-causing E326K mutation on this surface impairs PNKP recruitment to damaged DNA in human cells.","method":"Recombinant complex purification, small-angle X-ray scattering (SAXS), hydrogen-deuterium exchange mass spectrometry, laser microirradiation recruitment assay in human cells","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structural analysis (SAXS, HDX-MS) combined with functional cellular recruitment assay and disease-mutation validation","pmids":["28453785"],"is_preprint":false},{"year":2017,"finding":"PNKP interacts with XRCC1 via two distinct sites: a high-affinity phosphorylation-dependent interaction through the PNKP FHA domain and a low-affinity interaction through the Rev1-interacting region (RIR) motif in XRCC1 (requiring three conserved phenylalanine residues). The low-affinity interaction stimulates PNKP kinase activity and promotes SSBR and cell survival. A bipartite model is proposed in which the high-affinity interaction tethers XRCC1 and PNKP to enable the stimulatory low-affinity interaction.","method":"Biochemical and biophysical interaction assays, mutagenesis of RIR phenylalanines, PNKP kinase activity assays, cell survival and SSBR assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — multiple orthogonal biochemical, biophysical, and cellular methods in one study identifying two distinct interaction sites","pmids":["28821613"],"is_preprint":false},{"year":2017,"finding":"PARP1 and PARP2 have overlapping roles in recruiting PNKP and XRCC1 to oxidative single-strand breaks in chromatin. Loss of both PARP1 and PARP2 (but not either alone) greatly reduces or ablates PNKP chromatin binding following H2O2 treatment, demonstrating that very low levels of ADP-ribosylation synthesized by either enzyme are sufficient for PNKP recruitment.","method":"Isogenic PARP1/PARP2 double-knockout human diploid cells, chromatin fractionation assays after H2O2 treatment, PARP inhibitor dose-response","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic epistasis using isogenic knockout cells with chromatin binding readout, multiple conditions tested","pmids":["27965414"],"is_preprint":false},{"year":2015,"finding":"Mutant ATXN3 (expanded polyQ) interacts with and inactivates PNKP in SCA3, resulting in inefficient DNA repair, persistent accumulation of DNA strand breaks, and chronic activation of ATM signaling. Either PNKP overexpression or pharmacological ATM inhibition blocked mutant ATXN3-mediated cell death, placing PNKP upstream of ATM-p53-PKCδ pro-apoptotic signaling.","method":"Co-immunoprecipitation of endogenous PNKP with mutant ATXN3, PNKP activity assays, DNA damage accumulation measurement, ATM inhibitor rescue, PNKP overexpression rescue in SCA3 cell and mouse models","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal interaction, enzymatic activity assay, genetic rescue experiments in multiple model systems","pmids":["25590633"],"is_preprint":false},{"year":2019,"finding":"HTT forms a transcription-coupled DNA repair (TCR) complex with POLR2A, ATXN3, PNKP, and CBP. Mutant HTT impairs PNKP activity and causes persistent DNA break accumulation in actively transcribed genes, and aberrant ATM activation. Increasing PNKP activity in mutant HTT cells improves genome integrity and cell survival.","method":"Co-immunoprecipitation of the TCR complex, PNKP activity assays in HD cell and transgenic mouse models, gene-specific DNA damage quantification, PNKP overexpression rescue","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Moderate — complex purification by Co-IP, functional enzymatic assays, and genetic rescue in multiple HD models","pmids":["30994454"],"is_preprint":false},{"year":2018,"finding":"PNKP FHA domain interactions with phosphorylated XRCC1 extend beyond the well-characterized residues 515–526. An XRCC1 fragment (residues 166–436) binds PNKP and DNA and efficiently activates PNKP kinase activity. XRCC1 SNP variants R194W and R280H show weaker binding to PNKP and severely reduced stimulation of PNKP activity, and cells expressing these variants show reduced PNKP recruitment to laser-microirradiation-induced damage.","method":"Biochemical binding assays, PNKP kinase activity assays with XRCC1 fragments and SNP variants, laser microirradiation live-cell recruitment assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical and cellular methods, single lab","pmids":["30446622"],"is_preprint":false},{"year":2017,"finding":"CK2-mediated phosphorylation of XRCC1 is required for PNKP recruitment to DNA damage sites. A phosphorylation-mutant XRCC1 failed to support PNKP-GFP recruitment to micro-irradiation-induced damage, while cells expressing XRCC1 phosphorylation mutant showed marked reversal of camptothecin hypersensitivity compared to Xrcc1-/- cells, suggesting a backup pathway for PNKP-independent end cleaning.","method":"Live-cell fluorescence microscopy of PNKP-GFP at micro-irradiation damage, stable expression of phosphorylation-mutant XRCC1 in Xrcc1-/- fibroblasts, clonogenic survival assay","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct imaging of recruitment with functional genetic validation, single lab","pmids":["29100039"],"is_preprint":false},{"year":2020,"finding":"Pathological PNKP mutations associated with MCSZ, AOA4, and CMT2B2 cause a significant defect in DNA single-strand break repair (SSBR) but not in DNA double-strand break repair (DSBR) in primary patient fibroblasts. Restoration of SSBR requires both PNKP's kinase and phosphatase activities and its FHA domain interaction with XRCC1. Reduced DNA phosphatase activity correlates with neurodevelopmental dysfunction, while reduced DNA kinase activity correlates with neurodegeneration.","method":"Alkaline comet assay and γH2AX immunofluorescence for SSBR and DSBR rates in primary patient fibroblasts, complementation with kinase-dead, phosphatase-dead, and FHA-mutant PNKP constructs","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple patient cell lines, domain-specific complementation with orthogonal repair assays in a single rigorous study","pmids":["32504494"],"is_preprint":false},{"year":2020,"finding":"The PNKP FHA domain (specifically Arg35 and Arg48) is essential for PNKP recruitment to DNA damage sites via interactions with XRCC1 and XRCC4. PNKP R35A/R48A mutant failed to accumulate at laser-induced damage tracks, and siRNA depletion of XRCC1 and/or XRCC4 reduced PNKP accumulation. Cells expressing the FHA mutant showed increased sensitivity to ionizing radiation, delayed SSB and DSB repair, and genome instability (micronuclei, chromosome bridges).","method":"Laser micro-irradiation with live-cell confocal imaging, siRNA knockdown of XRCC1/XRCC4, PNKP FHA domain point mutants, clonogenic survival, comet assay, γH2AX foci, micronuclei/chromosome bridge scoring","journal":"Mutation research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (imaging, knockdown, mutagenesis, repair assays, cytogenetics) in a single study","pmids":["33220551"],"is_preprint":false},{"year":2023,"finding":"A conserved glutamine mutation in PNKP causing AOA4 does not significantly reduce enzymatic activities in vitro, but severely abrogates nuclear localization of PNKP. The mutant PNKP fails to interact with importin alpha (but not importin beta), blocking nuclear import. Western blot of AOA4 patient PBMCs confirmed cytoplasmic retention of mutant PNKP. Cells expressing mutant PNKP accumulate DNA double-strand breaks and activate DNA damage response pathways despite normal enzymatic activity.","method":"In vitro enzymatic activity assays, immunofluorescence for subcellular localization, co-immunoprecipitation with importin alpha/beta, Western blotting of patient-derived PBMCs, γH2AX assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods linking localization defect to interaction loss and functional consequence, validated in patient cells","pmids":["37061005"],"is_preprint":false},{"year":2024,"finding":"PNKP interacts with the nuclear isoform of PFKFB3, and PFKFB3's product fructose-2,6-bisphosphate (F2,6BP) acts as a cofactor that is required for PNKP activity. PFKFB3 depletion markedly abrogates PNKP activity without changing its protein level. F2,6BP levels are significantly lower in nuclear extracts from postmortem HD and SCA3 patient brains; supplementation of F2,6BP restored PNKP activity in these extracts and rescued genome integrity and HD phenotypes in Drosophila.","method":"Co-immunoprecipitation of PNKP with PFKFB3, PNKP activity assays with/without F2,6BP supplementation in nuclear extracts, PFKFB3 siRNA depletion, rescue in Drosophila HD model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — biochemical reconstitution of cofactor dependence, patient brain tissue validation, and in vivo rescue in Drosophila","pmids":["39298485"],"is_preprint":false},{"year":2024,"finding":"PNKP participates in DNA replication by functioning at replication forks, associating with PCNA, and contributing to Okazaki fragment (OF) maturation. CDK1/2 phosphorylate PNKP at multiple residues; mutation of these phosphorylation sites impairs PNKP function in DNA replication. Cellular depletion of PNKP produces defects similar to those of other OFM-related proteins.","method":"iPOND/replication fork enrichment, co-immunoprecipitation with PCNA, CDK1/2 kinase assays with PNKP, phosphorylation site mutagenesis, replication fork dynamics assays after PNKP depletion","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays in single lab; replication fork localization and PCNA interaction established","pmids":["39395804"],"is_preprint":false},{"year":2025,"finding":"CDK-mediated phosphorylation of PNKP at threonine 118 (T118) is required for PNKP recruitment to ssDNA gaps between Okazaki fragments during DNA replication. T118A-expressing cells accumulate ssDNA gaps in S phase and show accelerated replication fork progression. PNKP is involved in PARP1-dependent replication gap filling as a backup pathway when OF ligation is impaired.","method":"T118A phospho-site mutagenesis, ssDNA gap detection in S phase, replication fork progression assays (DNA fiber analysis), PARP1-dependent gap filling assay","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — phospho-site mutagenesis with multiple orthogonal replication assays defining mechanism at Okazaki fragments","pmids":["40146629"],"is_preprint":false},{"year":2024,"finding":"PNKP localizes at stalled replication forks and protects them from nucleolytic degradation of nascent DNA. Loss of PNKP leads to TOP1-dependent nascent DNA degradation at stalled forks (distinct from the BRCA2-dependent pathway). Hydroxyurea treatment causes ribonucleotide misincorporation that traps TOP1 at stalled forks; reducing TOP1 or TDP1 reverses nascent DNA degradation in PNKP-deficient cells.","method":"iPOND for fork localization, DNA fiber analysis for nascent strand degradation, epistasis with BRCA2, TDP1 and TOP1 knockdown rescue experiments","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct fork localization, genetic epistasis, mechanistic pathway placement with multiple rescue experiments","pmids":["39671289"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structure of the NHEJ short-range synaptic complex shows Pol λ and PNKP simultaneously bound to the complex, demonstrating that NHEJ can form large multifunctional end-processing complexes. The structure reveals the mode of Pol λ recruitment and establishes coordinated end-processing by both factors at the short-range synaptic complex.","method":"Cryo-EM structure determination of NHEJ short-range synaptic complex with Pol λ and PNKP","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — cryo-EM structure is Tier 1, but preprint and limited functional validation reported in abstract","pmids":["40501590"],"is_preprint":true},{"year":2022,"finding":"ZIKV infection relocalizes PNKP from the nucleus to the cytoplasm in neural progenitor cells (NPC), colocalizing with ZIKV replication factory marker NS1, causing functional nuclear PNKP depletion and DNA damage accumulation. Two PNKP phosphatase inhibitors or PNKP knockout inhibited ZIKV replication, indicating PNKP is a host factor required for ZIKV replication.","method":"Immunofluorescence colocalization of PNKP with NS1 in infected NPC, PNKP inhibitors and PNKP knockout to assess ZIKV replication, γH2AX for DNA damage, Chk1/Chk2 activation assays","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiments combined with genetic (KO) and pharmacological functional validation in two orthogonal approaches","pmids":["35412344"],"is_preprint":false},{"year":2025,"finding":"In atherosclerosis, macrophage-derived exosomal miR-146a-5p suppresses PNKP expression; reduced PNKP decreases its interaction with DDOST, leading to enhanced DDOST phosphorylation and activation of JAGN1-dependent NET formation in neutrophils.","method":"Co-immunoprecipitation of PNKP with DDOST, Western blot, qRT-PCR, dual-luciferase reporter, RIP assay in ApoE-/- mouse model and ox-LDL-stimulated macrophages","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 3 / Weak — Co-IP establishes interaction, but mechanism is single-lab and involves non-canonical PNKP function outside DNA repair","pmids":["41109654"],"is_preprint":false},{"year":2023,"finding":"PNKP is acetylated at two lysine residues in different domains: K142 is constitutively acetylated by p300, while K226 is acetylated by CBP only after DSB induction. AcK142-PNKP associates exclusively with BER/SSBR proteins and AcK226-PNKP exclusively with DSBR proteins. Cells expressing non-acetylable K142R or K226R PNKP accumulate DNA damage specifically in transcribed genes. In HD striatal neuronal cells, K142 but not K226 was acetylated, consistent with CBP degradation in HD.","method":"Site-specific acetylation identification, Co-IP with acetylation-specific antibodies, p300/CBP knockdown/identification as acetyltransferases, non-acetylable mutant cell lines, γH2AX assay, chromatin-immunoprecipitation with Ac-PNKP antibodies","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods identifying writers and functional consequences; preprint status lowers confidence","pmids":["37645927"],"is_preprint":true},{"year":2025,"finding":"HTT organizes a mitochondrial DNA repair complex containing HTT, mitochondrial RNA polymerase, transcription factors, and PNKP. Mutant HTT impairs this complex causing persistent mitochondrial DNA lesions. Restoring PNKP expression in a Drosophila HD model improves mitochondrial genome integrity and ameliorates motor deficits.","method":"Co-immunoprecipitation of mitochondrial repair complex components, mitochondrial DNA damage assays, PNKP overexpression rescue in Drosophila HD model","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — Co-IP and genetic rescue in Drosophila; preprint, single lab, limited validation","pmids":["bio_10.1101_2025.07.24.666629"],"is_preprint":true},{"year":2024,"finding":"PNKP is present in mitochondria and its activity is decreased in mitochondrial extracts from HD patient brains due to reduced PFKFB3 and F2,6BP levels. PFKFB3 is part of a mitochondrial DNA repair complex containing HTT, PNKP, DNA Pol γ (POLG), and Lig IIIα. PNKP binds F2,6BP with Kd ~525 nM. Addition of F2,6BP restored PNKP activity in HD mitochondrial extracts and restored mitochondrial genome integrity in HD cells and Drosophila.","method":"Subcellular fractionation and PNKP activity assay in mitochondrial extracts, Co-IP of mitochondrial repair complex, F2,6BP binding assay (Kd measurement), F2,6BP supplementation rescue in HD cells and Drosophila","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1-2 / Weak — biochemical binding assay and mitochondrial localization with complex purification; preprint, single lab","pmids":["bio_10.1101_2024.11.04.621834"],"is_preprint":true},{"year":2024,"finding":"HTT coordinates a Transcription-Coupled NHEJ (TC-NHEJ) complex containing PNKP, Ku70/80, XRCC4, and chromatin remodeler BRG1 to resolve transcription-associated DSBs in brain. HTT recruitment to DSBs in transcriptionally active gene-rich regions is BRG1-dependent, while efficient recruitment of TC-NHEJ proteins including PNKP is HTT-dependent. PNKP overexpression in a Drosophila HD model restores TC-NHEJ, improving genome integrity, motor defects, and lifespan.","method":"Co-immunoprecipitation of TC-NHEJ complex, ChIP at DSBs, BRG1/HTT dependency assays by knockdown, PNKP overexpression in Drosophila HD model rescue","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal biochemical and genetic experiments, preprint status limits confidence","pmids":["bio_10.1101_2024.09.19.613927"],"is_preprint":true},{"year":2025,"finding":"PNKP targeting in TNBC activates ferroptosis through the autophagic machinery. PNKP and STAT3 are rapidly phosphorylated, colocalize, and interact upon ferroptosis induction or doxorubicin treatment. PNKP inhibition activates STING and inhibits STAT3, increasing ferritinophagy and intracellular iron levels while decreasing GPX4 and SCD1. PNKP inhibition synergized with doxorubicin in TNBC animal models and patient-derived organoids.","method":"Co-immunoprecipitation of PNKP with STAT3, immunofluorescence colocalization, transcriptomic profiling, ferroptosis markers (ROS, glutathione, SCD1, GPX4), animal model and organoid therapeutic experiments","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP and colocalization with functional mechanistic pathway data; novel non-canonical PNKP function, single lab","pmids":["40743845"],"is_preprint":false}],"current_model":"PNKP is a bifunctional nuclear (and mitochondrial) DNA repair enzyme with DNA 3'-phosphatase and DNA 5'-kinase activities that processes damaged DNA termini in multiple repair pathways (BER, SSBR, NHEJ, TCR, and Okazaki fragment maturation); it is recruited to single-strand breaks via a bipartite interaction between its FHA domain and XRCC1 (phosphorylated by CK2), is recruited to NHEJ via XRCC4-LigIV interaction, is stabilized by ATM-mediated phosphorylation at S114/S126 that prevents Cul4A-DDB1-STRAP-mediated proteasomal degradation, has its activity allosterically modulated by F2,6BP (produced by PFKFB3), is regulated by CDK1/2-mediated phosphorylation at T118 for Okazaki fragment gap filling, is site-specifically acetylated by p300 (K142, directing BER/SSBR) and CBP (K226, directing DSBR) to partition it between repair pathways, and forms transcription-coupled repair complexes with HTT/POLR2A/ATXN3/CBP whose functional integrity is disrupted by polyglutamine-expanded proteins in HD and SCA3."},"narrative":{"mechanistic_narrative":"PNKP is a bifunctional DNA repair enzyme that processes damaged DNA termini through its DNA 5'-kinase and 3'-phosphatase activities, generating ligatable ends required across single-strand break repair (SSBR), non-homologous end joining (NHEJ), and DNA replication [PMID:10446192, PMID:32504494]. It is recruited to single-strand breaks through a bipartite mechanism in which its FHA domain (notably Arg35/Arg48) binds CK2-phosphorylated XRCC1 with high affinity to tether the proteins, while a second low-affinity contact through the XRCC1 RIR motif stimulates PNKP kinase activity; PARP1/PARP2-dependent ADP-ribosylation underpins this recruitment to oxidative breaks [PMID:28453785, PMID:28821613, PMID:27965414, PMID:29100039, PMID:33220551]. In NHEJ, the same FHA domain and a phosphatase-domain surface engage CK2-phosphorylated XRCC4-LigIV, positioning PNKP within multifunctional end-processing synaptic complexes [PMID:28453785, PMID:33220551]. PNKP abundance and localization are tightly regulated: ATM-mediated phosphorylation at S114/S126 blocks Cul4A-DDB1-STRAP-dependent proteasomal degradation, importin-alpha mediates its nuclear import, and PFKFB3-derived fructose-2,6-bisphosphate acts as a required cofactor for its catalytic activity [PMID:23042680, PMID:37061005, PMID:39298485]. PNKP also functions at replication forks, where CDK1/2 phosphorylation (including at T118) directs it to ssDNA gaps for Okazaki fragment maturation and PARP1-dependent backup gap filling, and where it protects stalled forks from TOP1-dependent nascent DNA degradation [PMID:39395804, PMID:40146629, PMID:39671289]. Loss of PNKP function causes human disease: distinct mutations underlie MCSZ, AOA4, and CMT2B2, with reduced phosphatase activity correlating with neurodevelopmental dysfunction and reduced kinase activity with neurodegeneration [PMID:22508754, PMID:32504494, PMID:37061005]. PNKP integrity is also compromised in polyglutamine disorders, where mutant ATXN3 and HTT impair PNKP within transcription-coupled repair complexes, driving DNA break accumulation and aberrant ATM signaling [PMID:25590633, PMID:30994454].","teleology":[{"year":1999,"claim":"Established the core biochemical identity of PNKP as a single enzyme carrying two distinct DNA-end-processing activities, defining its fundamental role in restoring repair-competent termini.","evidence":"GST-PNKP in vitro kinase/phosphatase assays plus E. coli xth nfo complementation","pmids":["10446192"],"confidence":"High","gaps":["Did not define recruitment partners or pathway context in mammalian cells","No structural basis for substrate selection"]},{"year":2012,"claim":"Linked PNKP enzymatic and stability defects to human disease, showing that disease mutations reduce kinase/phosphatase activity, lower protein levels, and impair cellular strand break repair.","evidence":"Recombinant mutant enzyme assays, Western blotting, and strand break repair assays in MCSZ patient cells","pmids":["22508754"],"confidence":"High","gaps":["Mechanism linking specific activity loss to neuronal phenotype not resolved here","Did not distinguish SSBR vs DSBR contributions"]},{"year":2012,"claim":"Defined how PNKP abundance is controlled by a damage-responsive switch, showing ATM phosphorylation stabilizes PNKP against Cul4A-DDB1-STRAP-mediated degradation.","evidence":"Phospho-site mapping, ubiquitylation assays, Cul4A-DDB1-STRAP purification, Strap-/- MEFs","pmids":["23042680"],"confidence":"High","gaps":["Stoichiometry and kinetics of the stabilization switch not quantified","Whether other kinases contribute is unaddressed"]},{"year":2015,"claim":"Connected PNKP dysfunction to polyglutamine neurodegeneration, showing mutant ATXN3 binds and inactivates PNKP upstream of ATM-p53-PKCδ apoptotic signaling.","evidence":"Co-IP, PNKP activity assays, ATM-inhibitor and PNKP-overexpression rescue in SCA3 cell and mouse models","pmids":["25590633"],"confidence":"High","gaps":["Molecular basis of mutant ATXN3-mediated inactivation undefined","Generalizability to other polyQ proteins not yet shown"]},{"year":2017,"claim":"Resolved how PNKP is integrated into both NHEJ and SSBR through FHA-domain interactions with phosphorylated XRCC4-LigIV and XRCC1, and established a bipartite tethering/stimulation model.","evidence":"SAXS, HDX-MS, recombinant complex assays, RIR mutagenesis, and laser-microirradiation recruitment in human cells","pmids":["28453785","28821613","29100039","27965414"],"confidence":"High","gaps":["High-resolution structure of full complexes not obtained","Quantitative contribution of each interaction in vivo not fully partitioned"]},{"year":2018,"claim":"Extended the XRCC1-PNKP interaction beyond the canonical phospho-segment and tied common XRCC1 SNPs to reduced PNKP recruitment and stimulation.","evidence":"Biochemical binding/activity assays with XRCC1 fragments and SNP variants plus laser-microirradiation recruitment","pmids":["30446622"],"confidence":"Medium","gaps":["Structural basis of the extended interaction not determined","Physiological impact of SNPs at organismal level unaddressed"]},{"year":2019,"claim":"Placed PNKP within an HTT-organized transcription-coupled repair complex, showing mutant HTT impairs PNKP and causes break accumulation in transcribed genes.","evidence":"Co-IP of HTT/POLR2A/ATXN3/PNKP/CBP complex, activity assays, and PNKP rescue in HD cell and mouse models","pmids":["30994454"],"confidence":"High","gaps":["Precise architecture of the TCR complex unresolved","How transcription couples to PNKP loading not mechanistically defined"]},{"year":2020,"claim":"Mapped genotype-to-pathway relationships across PNKP-linked diseases and proved an essential role for the FHA domain in recruitment and genome stability.","evidence":"Comet/γH2AX repair assays in patient fibroblasts with domain-specific complementation, plus FHA point mutants and XRCC1/XRCC4 depletion with cytogenetic readouts","pmids":["32504494","33220551"],"confidence":"High","gaps":["Why phosphatase loss preferentially drives neurodevelopmental vs kinase loss neurodegenerative phenotypes not mechanistically explained"]},{"year":2023,"claim":"Revealed that subcellular localization, not catalysis, is the defect in AOA4, establishing importin-alpha-dependent nuclear import as essential for PNKP function.","evidence":"In vitro activity assays, immunofluorescence, importin alpha/beta Co-IP, and patient PBMC Western blots","pmids":["37061005"],"confidence":"High","gaps":["Nuclear localization signal not precisely mapped","Whether import is regulated dynamically during the cell cycle unknown"]},{"year":2024,"claim":"Identified a metabolic cofactor requirement for PNKP, showing PFKFB3-derived fructose-2,6-bisphosphate is needed for activity and is deficient in polyQ disease brains.","evidence":"PFKFB3 Co-IP, F2,6BP supplementation and depletion in nuclear/mitochondrial extracts, Kd measurement, and Drosophila HD rescue","pmids":["39298485","bio_10.1101_2024.11.04.621834"],"confidence":"High","gaps":["Allosteric mechanism by which F2,6BP modulates catalysis not structurally defined","Whether cofactor levels are dynamically regulated under stress unclear"]},{"year":2024,"claim":"Defined a replication-associated role for PNKP at forks, including Okazaki fragment maturation, PCNA association, and protection of stalled forks from TOP1-dependent degradation.","evidence":"iPOND, PCNA Co-IP, CDK1/2 kinase and phospho-site assays, DNA fiber analysis, and TOP1/TDP1 epistasis","pmids":["39395804","39671289","40146629"],"confidence":"High","gaps":["Relative importance of replicative vs repair functions in tissues not weighed","Coordination between fork-protection and gap-filling roles undefined"]},{"year":2023,"claim":"Proposed acetylation as a pathway-partitioning code, with p300-mediated K142 directing BER/SSBR and CBP-mediated K226 directing DSBR.","evidence":"Site-specific acetylation mapping, acetyl-specific Co-IP and ChIP, p300/CBP knockdown, and non-acetylable mutant cells (preprint)","pmids":["37645927"],"confidence":"Medium","gaps":["Preprint status; awaits peer-reviewed confirmation","How acetylation switches partner selection mechanistically unresolved"]},{"year":2025,"claim":"Extended PNKP's repair role to NHEJ synaptic architecture and to mitochondrial and transcription-coupled NHEJ complexes, while uncovering non-canonical roles in ZIKV replication, atherosclerosis, and TNBC ferroptosis.","evidence":"Cryo-EM of NHEJ synaptic complex with Pol λ and PNKP (preprint), Co-IP of TC-NHEJ and mitochondrial repair complexes (preprints), and Co-IP/functional assays for DDOST, STAT3, and ZIKV NS1 interactions","pmids":["40501590","bio_10.1101_2024.09.19.613927","bio_10.1101_2025.07.24.666629","35412344","41109654","40743845"],"confidence":"Medium","gaps":["Several findings are preprints or single-lab studies","Non-canonical PNKP functions outside DNA repair are not mechanistically integrated with its enzymatic activity"]},{"year":null,"claim":"How PNKP's multiple regulatory layers — phosphorylation, acetylation, nuclear import, and metabolic cofactor supply — are integrated to partition the single enzyme among SSBR, NHEJ, replication, and mitochondrial repair in different cell types remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model of regulated pathway selection","Tissue-specific determinants of PNKP function in neurons vs proliferating cells unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,1,10]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,10]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,10]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,8]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[12,18]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[21,22]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[11,16]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[0,3,10,11]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[14,15,16]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,6,7,10,12]}],"complexes":["XRCC4-LigIV NHEJ complex","NHEJ short-range synaptic complex","HTT/POLR2A/ATXN3/PNKP/CBP transcription-coupled repair complex","HTT mitochondrial DNA repair complex"],"partners":["XRCC1","XRCC4","LIG4","PCNA","PFKFB3","ATXN3","HTT","POLR2A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96T60","full_name":"Bifunctional polynucleotide phosphatase/kinase","aliases":["DNA 5'-kinase/3'-phosphatase","Polynucleotide kinase-3'-phosphatase"],"length_aa":521,"mass_kda":57.1,"function":"Plays a key role in the repair of DNA damage, functioning as part of both the non-homologous end-joining (NHEJ) and base excision repair (BER) pathways (PubMed:10446192, PubMed:10446193, PubMed:15385968, PubMed:20852255, PubMed:28453785). Through its two catalytic activities, PNK ensures that DNA termini are compatible with extension and ligation by either removing 3'-phosphates from, or by phosphorylating 5'-hydroxyl groups on, the ribose sugar of the DNA backbone (PubMed:10446192, PubMed:10446193)","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q96T60/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PNKP","classification":"Not Classified","n_dependent_lines":637,"n_total_lines":1208,"dependency_fraction":0.527317880794702},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"PARP1","stoichiometry":0.2},{"gene":"SSRP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/PNKP","total_profiled":1310},"omim":[{"mim_id":"617633","title":"SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26","url":"https://www.omim.org/entry/617633"},{"mim_id":"616267","title":"ATAXIA-OCULOMOTOR APRAXIA 4; AOA4","url":"https://www.omim.org/entry/616267"},{"mim_id":"613402","title":"MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY; MCSZ","url":"https://www.omim.org/entry/613402"},{"mim_id":"611035","title":"APRATAXIN- AND PNKP-LIKE FACTOR; APLF","url":"https://www.omim.org/entry/611035"},{"mim_id":"610606","title":"CYTOPLASMIC POLYADENYLATION ELEMENT-BINDING PROTEIN 3; CPEB3","url":"https://www.omim.org/entry/610606"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PNKP"},"hgnc":{"alias_symbol":["PNK"],"prev_symbol":[]},"alphafold":{"accession":"Q96T60","domains":[{"cath_id":"2.60.200.20","chopping":"9-108","consensus_level":"high","plddt":92.6985,"start":9,"end":108},{"cath_id":"3.40.50.1000","chopping":"147-330","consensus_level":"high","plddt":96.7521,"start":147,"end":330},{"cath_id":"3.40.50.300","chopping":"367-517","consensus_level":"high","plddt":95.9606,"start":367,"end":517}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96T60","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96T60-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96T60-F1-predicted_aligned_error_v6.png","plddt_mean":90.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PNKP","jax_strain_url":"https://www.jax.org/strain/search?query=PNKP"},"sequence":{"accession":"Q96T60","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96T60.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96T60/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96T60"}},"corpus_meta":[{"pmid":"10446192","id":"PMC_10446192","title":"Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3'-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10446192","citation_count":246,"is_preprint":false},{"pmid":"20118933","id":"PMC_20118933","title":"Mutations in PNKP cause microcephaly, seizures and defects in DNA repair.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20118933","citation_count":233,"is_preprint":false},{"pmid":"27965414","id":"PMC_27965414","title":"Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27965414","citation_count":166,"is_preprint":false},{"pmid":"25728773","id":"PMC_25728773","title":"Mutations in PNKP cause recessive ataxia with oculomotor apraxia type 4.","date":"2015","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25728773","citation_count":109,"is_preprint":false},{"pmid":"30994454","id":"PMC_30994454","title":"Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30994454","citation_count":107,"is_preprint":false},{"pmid":"25590633","id":"PMC_25590633","title":"Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25590633","citation_count":72,"is_preprint":false},{"pmid":"23224214","id":"PMC_23224214","title":"Progressive cerebellar atrophy and polyneuropathy: expanding the spectrum of PNKP mutations.","date":"2012","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/23224214","citation_count":68,"is_preprint":false},{"pmid":"22508754","id":"PMC_22508754","title":"Impact of PNKP mutations associated with microcephaly, seizures and developmental delay on enzyme activity and DNA strand break repair.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22508754","citation_count":61,"is_preprint":false},{"pmid":"27125728","id":"PMC_27125728","title":"Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease.","date":"2016","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/27125728","citation_count":50,"is_preprint":false},{"pmid":"28453785","id":"PMC_28453785","title":"Structural and functional characterization of the PNKP-XRCC4-LigIV DNA repair complex.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28453785","citation_count":47,"is_preprint":false},{"pmid":"23042680","id":"PMC_23042680","title":"Phosphorylation of PNKP by ATM prevents its proteasomal degradation and enhances resistance to oxidative stress.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23042680","citation_count":38,"is_preprint":false},{"pmid":"32504494","id":"PMC_32504494","title":"Pathological mutations in PNKP trigger defects in DNA single-strand break repair but not DNA double-strand break repair.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32504494","citation_count":34,"is_preprint":false},{"pmid":"30039206","id":"PMC_30039206","title":"The polynucleotide kinase 3'-phosphatase gene (PNKP) is involved in Charcot-Marie-Tooth disease (CMT2B2) previously related to MED25.","date":"2018","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/30039206","citation_count":28,"is_preprint":false},{"pmid":"27066567","id":"PMC_27066567","title":"Mutation in PNKP presenting initially as axonal Charcot-Marie-Tooth disease.","date":"2015","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27066567","citation_count":26,"is_preprint":false},{"pmid":"22308407","id":"PMC_22308407","title":"The adenylyltransferase domain of bacterial Pnkp defines a unique RNA ligase family.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22308407","citation_count":25,"is_preprint":false},{"pmid":"24965255","id":"PMC_24965255","title":"Causative novel PNKP mutations and concomitant PCDH15 mutations in a patient with microcephaly with early-onset seizures and developmental delay syndrome and hearing loss.","date":"2014","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24965255","citation_count":22,"is_preprint":false},{"pmid":"29320576","id":"PMC_29320576","title":"Targeting DNA repair with PNKP inhibition sensitizes radioresistant prostate cancer cells to high LET radiation.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29320576","citation_count":20,"is_preprint":false},{"pmid":"31436889","id":"PMC_31436889","title":"From congenital microcephaly to adult onset cerebellar ataxia: Distinct and overlapping phenotypes in patients with PNKP gene mutations.","date":"2019","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/31436889","citation_count":18,"is_preprint":false},{"pmid":"22847431","id":"PMC_22847431","title":"Molecular basis of bacterial protein Hen1 activating the ligase activity of bacterial protein Pnkp for RNA repair.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22847431","citation_count":18,"is_preprint":false},{"pmid":"30446622","id":"PMC_30446622","title":"Domain analysis of PNKP-XRCC1 interactions: Influence of genetic variants of XRCC1.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30446622","citation_count":17,"is_preprint":false},{"pmid":"29688721","id":"PMC_29688721","title":"Nanoencapsulation of Novel Inhibitors of PNKP for Selective Sensitization to Ionizing Radiation and Irinotecan and Induction of Synthetic Lethality.","date":"2018","source":"Molecular pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/29688721","citation_count":17,"is_preprint":false},{"pmid":"23118415","id":"PMC_23118415","title":"Structure and mechanism of the polynucleotide kinase component of the bacterial Pnkp-Hen1 RNA repair system.","date":"2012","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23118415","citation_count":17,"is_preprint":false},{"pmid":"35412344","id":"PMC_35412344","title":"Zika Virus Induces Mitotic Catastrophe in Human Neural Progenitors by Triggering Unscheduled Mitotic Entry in the Presence of DNA Damage While Functionally Depleting Nuclear PNKP.","date":"2022","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/35412344","citation_count":17,"is_preprint":false},{"pmid":"31041400","id":"PMC_31041400","title":"Novel PNKP mutations causing defective DNA strand break repair and PARP1 hyperactivity in MCSZ.","date":"2019","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31041400","citation_count":16,"is_preprint":false},{"pmid":"28821613","id":"PMC_28821613","title":"The Rev1 interacting region (RIR) motif in the scaffold protein XRCC1 mediates a low-affinity interaction with polynucleotide kinase/phosphatase (PNKP) during DNA single-strand break repair.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28821613","citation_count":16,"is_preprint":false},{"pmid":"28552035","id":"PMC_28552035","title":"Novel PNKP mutation in siblings with ataxia-oculomotor apraxia type 4.","date":"2017","source":"Journal of neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/28552035","citation_count":16,"is_preprint":false},{"pmid":"35354845","id":"PMC_35354845","title":"Mutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35354845","citation_count":15,"is_preprint":false},{"pmid":"31061747","id":"PMC_31061747","title":"Ataxia with Oculomotor Apraxia Type 4 with PNKP Common \"Portuguese\" and Novel Mutations in Two Belarusian Families.","date":"2019","source":"Journal of pediatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31061747","citation_count":15,"is_preprint":false},{"pmid":"29100039","id":"PMC_29100039","title":"XRCC1-mediated repair of strand breaks independent of PNKP binding.","date":"2017","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/29100039","citation_count":14,"is_preprint":false},{"pmid":"23595150","id":"PMC_23595150","title":"Structure and mechanism of the 2',3' phosphatase component of the bacterial Pnkp-Hen1 RNA repair system.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/23595150","citation_count":14,"is_preprint":false},{"pmid":"32980744","id":"PMC_32980744","title":"The Phenotypic Spectrum of PNKP-Associated Disease and the Absence of Immunodeficiency and Cancer Predisposition in a Dutch Cohort.","date":"2020","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32980744","citation_count":13,"is_preprint":false},{"pmid":"30195441","id":"PMC_30195441","title":"Multi affected pedigree with congenital microcephaly: WES revealed PNKP gene mutation.","date":"2018","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/30195441","citation_count":13,"is_preprint":false},{"pmid":"33933518","id":"PMC_33933518","title":"A synthetically lethal nanomedicine delivering novel inhibitors of polynucleotide kinase 3'-phosphatase (PNKP) for targeted therapy of PTEN-deficient colorectal cancer.","date":"2021","source":"Journal of controlled release : official journal of the Controlled Release Society","url":"https://pubmed.ncbi.nlm.nih.gov/33933518","citation_count":13,"is_preprint":false},{"pmid":"29498415","id":"PMC_29498415","title":"Rare compound heterozygous variants in PNKP identified by whole exome sequencing in a German patient with ataxia-oculomotor apraxia 4 and pilocytic astrocytoma.","date":"2018","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29498415","citation_count":13,"is_preprint":false},{"pmid":"33220551","id":"PMC_33220551","title":"The FHA domain of PNKP is essential for its recruitment to DNA damage sites and maintenance of genome stability.","date":"2020","source":"Mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/33220551","citation_count":12,"is_preprint":false},{"pmid":"39578729","id":"PMC_39578729","title":"Plasma pQTL and brain eQTL integration identifies PNKP as a therapeutic target and reveals mechanistic insights into migraine pathophysiology.","date":"2024","source":"The journal of headache and pain","url":"https://pubmed.ncbi.nlm.nih.gov/39578729","citation_count":11,"is_preprint":false},{"pmid":"37061005","id":"PMC_37061005","title":"Functional analysis of a conserved site mutation in the DNA end processing enzyme PNKP leading to ataxia with oculomotor apraxia type 4 in humans.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37061005","citation_count":11,"is_preprint":false},{"pmid":"23721485","id":"PMC_23721485","title":"Structural and biochemical analysis of the phosphate donor specificity of the polynucleotide kinase component of the bacterial pnkp•hen1 RNA repair system.","date":"2013","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23721485","citation_count":11,"is_preprint":false},{"pmid":"22190744","id":"PMC_22190744","title":"Probing the substrate specificity of the bacterial Pnkp/Hen1 RNA repair system using synthetic RNAs.","date":"2011","source":"RNA (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/22190744","citation_count":11,"is_preprint":false},{"pmid":"34226276","id":"PMC_34226276","title":"PNKP is required for maintaining the integrity of progenitor cell populations in adult mice.","date":"2021","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/34226276","citation_count":9,"is_preprint":false},{"pmid":"35004293","id":"PMC_35004293","title":"Nano-Delivery of a Novel Inhibitor of Polynucleotide Kinase/Phosphatase (PNKP) for Targeted Sensitization of Colorectal Cancer to Radiation-Induced DNA Damage.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35004293","citation_count":9,"is_preprint":false},{"pmid":"27232581","id":"PMC_27232581","title":"Microcephalic primordial dwarfism in an Emirati patient with PNKP mutation.","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/27232581","citation_count":8,"is_preprint":false},{"pmid":"34456161","id":"PMC_34456161","title":"Discovery of potential inhibitors targeting the kinase domain of polynucleotide kinase/phosphatase (PNKP): Homology modeling, virtual screening based on multiple conformations, and molecular dynamics simulation.","date":"2021","source":"Computational biology and chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34456161","citation_count":8,"is_preprint":false},{"pmid":"30956058","id":"PMC_30956058","title":"PNKP deficiency mimicking a benign hereditary chorea: The misleading presentation of a neurodegenerative disorder.","date":"2019","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/30956058","citation_count":8,"is_preprint":false},{"pmid":"39298485","id":"PMC_39298485","title":"Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington's disease.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/39298485","citation_count":7,"is_preprint":false},{"pmid":"33332469","id":"PMC_33332469","title":"Mutational survivorship bias: The case of PNKP.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/33332469","citation_count":7,"is_preprint":false},{"pmid":"37916443","id":"PMC_37916443","title":"Novel PNKP mutations associated with reduced DNA single-strand break repair and severe microcephaly, seizures, and developmental delay.","date":"2023","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37916443","citation_count":5,"is_preprint":false},{"pmid":"34697416","id":"PMC_34697416","title":"Prenatal phenotype of PNKP-related primary microcephaly associated with variants affecting both the FHA and phosphatase domain.","date":"2021","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/34697416","citation_count":5,"is_preprint":false},{"pmid":"40743845","id":"PMC_40743845","title":"PNKP targeting engages the autophagic machinery through STING and STAT3 to potentiate ferroptosis and chemotherapy in TNBC.","date":"2025","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/40743845","citation_count":4,"is_preprint":false},{"pmid":"39395804","id":"PMC_39395804","title":"CDK-dependent phosphorylation regulates PNKP function in DNA replication.","date":"2024","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39395804","citation_count":4,"is_preprint":false},{"pmid":"31707899","id":"PMC_31707899","title":"Compound Heterozygous Mutations in PNKP Gene in an Iranian Child with Microcephaly, Seizures, and Developmental Delay.","date":"2019","source":"Fetal and pediatric pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31707899","citation_count":4,"is_preprint":false},{"pmid":"39671289","id":"PMC_39671289","title":"PNKP safeguards stalled replication forks from nuclease-dependent degradation during replication stress.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/39671289","citation_count":3,"is_preprint":false},{"pmid":"24213989","id":"PMC_24213989","title":"PNKP knockdown by RNA interference inhibits herpes simplex virus-1 replication in astrocytes.","date":"2013","source":"Virologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/24213989","citation_count":3,"is_preprint":false},{"pmid":"40146629","id":"PMC_40146629","title":"CDK-mediated phosphorylation of PNKP is required for end-processing of single-strand DNA gaps on Okazaki fragments and genome stability.","date":"2025","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/40146629","citation_count":2,"is_preprint":false},{"pmid":"40501590","id":"PMC_40501590","title":"End Processing in NHEJ by Polymerase λ and PNKP is coordinated during short-range synapsis.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40501590","citation_count":2,"is_preprint":false},{"pmid":"41109654","id":"PMC_41109654","title":"Macrophage-derived exosome miR-146a-5p modulates PNKP/DDOST/JAGN1 complex to regulate NETs formation in atherosclerosis.","date":"2025","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/41109654","citation_count":2,"is_preprint":false},{"pmid":"39417375","id":"PMC_39417375","title":"Characterization of Two Novel PNKP Splice-Site Variants in a Proband With Microcephaly, Intellectual Disability, and Multiple Malformations.","date":"2024","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39417375","citation_count":2,"is_preprint":false},{"pmid":"39833032","id":"PMC_39833032","title":"Prenatal phenotype of PNKP-related microcephaly, seizures, and developmental delay: A case report and literature review.","date":"2025","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39833032","citation_count":1,"is_preprint":false},{"pmid":"38785196","id":"PMC_38785196","title":"Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer.","date":"2024","source":"Molecular pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/38785196","citation_count":1,"is_preprint":false},{"pmid":"26695908","id":"PMC_26695908","title":"Expression of Cyclin d1 protein and CCND1 та PNKP genes in peripheral blood mononuclear cells in clean up worker of Chornobyl accident with different state of immune system.","date":"2015","source":"Problemy radiatsiinoi medytsyny ta radiobiolohii","url":"https://pubmed.ncbi.nlm.nih.gov/26695908","citation_count":1,"is_preprint":false},{"pmid":"40687947","id":"PMC_40687947","title":"B-cell immunodeficiency associated with polynucleotide kinase 3'-phosphatase (PNKP) deficiency.","date":"2025","source":"The journal of allergy and clinical immunology. Global","url":"https://pubmed.ncbi.nlm.nih.gov/40687947","citation_count":0,"is_preprint":false},{"pmid":"37645927","id":"PMC_37645927","title":"Site-specific acetylation of polynucleotide kinase 3'-phosphatase (PNKP) regulates its distinct role in DNA repair pathways.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37645927","citation_count":0,"is_preprint":false},{"pmid":"37961108","id":"PMC_37961108","title":"Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington's disease.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37961108","citation_count":0,"is_preprint":false},{"pmid":"36558152","id":"PMC_36558152","title":"Self-Supplying Guide RNA-Mediated CRISPR/Cas12a Fluorescence System for Sensitive Detection of T4 PNKP.","date":"2022","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36558152","citation_count":0,"is_preprint":false},{"pmid":"41283299","id":"PMC_41283299","title":"Compound Heterozygous PNKP Variants Causing Developmental and Epileptic Encephalopathy with Severe Microcephaly: Natural History of Two New Cases and Literature Review.","date":"2025","source":"NeuroSci","url":"https://pubmed.ncbi.nlm.nih.gov/41283299","citation_count":0,"is_preprint":false},{"pmid":"41983441","id":"PMC_41983441","title":"Deficiency of pnkp in zebrafish causes microcephaly, seizures, and developmental delay through mitochondrial dysfunction.","date":"2026","source":"Zoological research","url":"https://pubmed.ncbi.nlm.nih.gov/41983441","citation_count":0,"is_preprint":false},{"pmid":"41982948","id":"PMC_41982948","title":"Microcephaly, seizures and developmental delay caused by two novel mutations in the PNKP gene: a case report.","date":"2026","source":"Translational pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/41982948","citation_count":0,"is_preprint":false},{"pmid":"41436176","id":"PMC_41436176","title":"Refining the phenotypic spectrum of PNKP-related microcephaly: a study of 27 new patients.","date":"2026","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41436176","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.26.659251","title":"Exercise serum promotes DNA damage repair and upregulates DNA repair gene  <i>PNKP</i>  in colon cancer cells","date":"2025-06-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.26.659251","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.24.666629","title":"Huntingtin preserves mitochondrial genome integrity in neurons, which is impaired in Huntington’s disease","date":"2025-07-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.24.666629","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.04.621834","title":"F2,6BP restores mitochondrial genome integrity in Huntington’s Disease","date":"2024-11-04","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.04.621834","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.13.623464","title":"Fructose-2,6-bisphosphate restores TDP-43 pathology-driven genome repair deficiency in motor neuron diseases","date":"2024-11-14","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.13.623464","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.09.19.613927","title":"Chromatin remodeler BRG1 recruits huntingtin to repair DNA double-strand breaks in neurons","date":"2024-09-20","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.19.613927","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":40512,"output_tokens":7503,"usd":0.117041,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16577,"output_tokens":4775,"usd":0.10113,"stage2_stop_reason":"end_turn"},"total_usd":0.218171,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"PNKP encodes a bifunctional enzyme with both DNA 5'-kinase and DNA 3'-phosphatase activities. A GST-PNKP fusion protein displayed both activities in vitro, and the 3'-phosphatase domain shows similarity to L-2-haloacid dehalogenases. PNKP expression rescued oxidative-damage sensitivity in E. coli xth nfo double mutants, demonstrating in vivo removal of 3'-phosphate groups to generate termini suitable for DNA polymerase.\",\n      \"method\": \"GST-fusion protein in vitro kinase/phosphatase assays, E. coli complementation rescue experiment, tryptic peptide sequencing from bovine enzyme\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro enzymatic reconstitution with fusion protein plus in vivo functional complementation, foundational characterization paper\",\n      \"pmids\": [\"10446192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MCSZ-associated PNKP mutations (L176F, T424Gfs48X, exon15Δfs4X, E326K) reduce or ablate DNA kinase activity in vitro and reduce cellular PNKP protein levels ~10-fold; all mutations result in reduced rates of chromosomal DNA strand break repair in cells. L176F also reduces phosphatase activity, while E326K destabilizes PNKP at physiological temperature.\",\n      \"method\": \"Recombinant PNKP in vitro kinase and phosphatase assays, Western blotting for cellular protein levels, chromosomal DNA strand break repair assays in patient-derived cells\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple mutants assessed with orthogonal in vitro and cellular assays in a single rigorous study\",\n      \"pmids\": [\"22508754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ATM phosphorylates PNKP at serines 114 and 126 in response to oxidative DNA damage, inhibiting ubiquitylation-dependent proteasomal degradation of PNKP and increasing its stability. The Cul4A-DDB1 ubiquitin ligase complex (with STRAP as adaptor) is responsible for PNKP ubiquitylation. Strap-/- MEFs have elevated PNKP levels and enhanced resistance to oxidative DNA damage.\",\n      \"method\": \"Phosphorylation site mapping, ubiquitylation assays, purification of Cul4A-DDB1-STRAP complex, Strap-/- mouse embryonic fibroblast analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — identification of writer kinase (ATM) and E3 ligase complex with multiple orthogonal methods and genetic validation in MEFs\",\n      \"pmids\": [\"23042680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PNKP forms a stable complex with XRCC4-LigIV in NHEJ. The PNKP FHA domain binds CK2-phosphorylated XRCC4 C-terminal tail; only one PNKP protomer binds per XRCC4 dimer. SAXS reveals a flexible multi-state complex with multipoint contacts between the PNKP FHA and catalytic domains and the XRCC4 coiled-coil/LigIV BRCT repeats. Hydrogen-deuterium exchange identifies a phosphatase domain surface contacting XRCC4-LigIV. The MCSZ-causing E326K mutation on this surface impairs PNKP recruitment to damaged DNA in human cells.\",\n      \"method\": \"Recombinant complex purification, small-angle X-ray scattering (SAXS), hydrogen-deuterium exchange mass spectrometry, laser microirradiation recruitment assay in human cells\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural analysis (SAXS, HDX-MS) combined with functional cellular recruitment assay and disease-mutation validation\",\n      \"pmids\": [\"28453785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PNKP interacts with XRCC1 via two distinct sites: a high-affinity phosphorylation-dependent interaction through the PNKP FHA domain and a low-affinity interaction through the Rev1-interacting region (RIR) motif in XRCC1 (requiring three conserved phenylalanine residues). The low-affinity interaction stimulates PNKP kinase activity and promotes SSBR and cell survival. A bipartite model is proposed in which the high-affinity interaction tethers XRCC1 and PNKP to enable the stimulatory low-affinity interaction.\",\n      \"method\": \"Biochemical and biophysical interaction assays, mutagenesis of RIR phenylalanines, PNKP kinase activity assays, cell survival and SSBR assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — multiple orthogonal biochemical, biophysical, and cellular methods in one study identifying two distinct interaction sites\",\n      \"pmids\": [\"28821613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PARP1 and PARP2 have overlapping roles in recruiting PNKP and XRCC1 to oxidative single-strand breaks in chromatin. Loss of both PARP1 and PARP2 (but not either alone) greatly reduces or ablates PNKP chromatin binding following H2O2 treatment, demonstrating that very low levels of ADP-ribosylation synthesized by either enzyme are sufficient for PNKP recruitment.\",\n      \"method\": \"Isogenic PARP1/PARP2 double-knockout human diploid cells, chromatin fractionation assays after H2O2 treatment, PARP inhibitor dose-response\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis using isogenic knockout cells with chromatin binding readout, multiple conditions tested\",\n      \"pmids\": [\"27965414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Mutant ATXN3 (expanded polyQ) interacts with and inactivates PNKP in SCA3, resulting in inefficient DNA repair, persistent accumulation of DNA strand breaks, and chronic activation of ATM signaling. Either PNKP overexpression or pharmacological ATM inhibition blocked mutant ATXN3-mediated cell death, placing PNKP upstream of ATM-p53-PKCδ pro-apoptotic signaling.\",\n      \"method\": \"Co-immunoprecipitation of endogenous PNKP with mutant ATXN3, PNKP activity assays, DNA damage accumulation measurement, ATM inhibitor rescue, PNKP overexpression rescue in SCA3 cell and mouse models\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal interaction, enzymatic activity assay, genetic rescue experiments in multiple model systems\",\n      \"pmids\": [\"25590633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HTT forms a transcription-coupled DNA repair (TCR) complex with POLR2A, ATXN3, PNKP, and CBP. Mutant HTT impairs PNKP activity and causes persistent DNA break accumulation in actively transcribed genes, and aberrant ATM activation. Increasing PNKP activity in mutant HTT cells improves genome integrity and cell survival.\",\n      \"method\": \"Co-immunoprecipitation of the TCR complex, PNKP activity assays in HD cell and transgenic mouse models, gene-specific DNA damage quantification, PNKP overexpression rescue\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — complex purification by Co-IP, functional enzymatic assays, and genetic rescue in multiple HD models\",\n      \"pmids\": [\"30994454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PNKP FHA domain interactions with phosphorylated XRCC1 extend beyond the well-characterized residues 515–526. An XRCC1 fragment (residues 166–436) binds PNKP and DNA and efficiently activates PNKP kinase activity. XRCC1 SNP variants R194W and R280H show weaker binding to PNKP and severely reduced stimulation of PNKP activity, and cells expressing these variants show reduced PNKP recruitment to laser-microirradiation-induced damage.\",\n      \"method\": \"Biochemical binding assays, PNKP kinase activity assays with XRCC1 fragments and SNP variants, laser microirradiation live-cell recruitment assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical and cellular methods, single lab\",\n      \"pmids\": [\"30446622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CK2-mediated phosphorylation of XRCC1 is required for PNKP recruitment to DNA damage sites. A phosphorylation-mutant XRCC1 failed to support PNKP-GFP recruitment to micro-irradiation-induced damage, while cells expressing XRCC1 phosphorylation mutant showed marked reversal of camptothecin hypersensitivity compared to Xrcc1-/- cells, suggesting a backup pathway for PNKP-independent end cleaning.\",\n      \"method\": \"Live-cell fluorescence microscopy of PNKP-GFP at micro-irradiation damage, stable expression of phosphorylation-mutant XRCC1 in Xrcc1-/- fibroblasts, clonogenic survival assay\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct imaging of recruitment with functional genetic validation, single lab\",\n      \"pmids\": [\"29100039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Pathological PNKP mutations associated with MCSZ, AOA4, and CMT2B2 cause a significant defect in DNA single-strand break repair (SSBR) but not in DNA double-strand break repair (DSBR) in primary patient fibroblasts. Restoration of SSBR requires both PNKP's kinase and phosphatase activities and its FHA domain interaction with XRCC1. Reduced DNA phosphatase activity correlates with neurodevelopmental dysfunction, while reduced DNA kinase activity correlates with neurodegeneration.\",\n      \"method\": \"Alkaline comet assay and γH2AX immunofluorescence for SSBR and DSBR rates in primary patient fibroblasts, complementation with kinase-dead, phosphatase-dead, and FHA-mutant PNKP constructs\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple patient cell lines, domain-specific complementation with orthogonal repair assays in a single rigorous study\",\n      \"pmids\": [\"32504494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The PNKP FHA domain (specifically Arg35 and Arg48) is essential for PNKP recruitment to DNA damage sites via interactions with XRCC1 and XRCC4. PNKP R35A/R48A mutant failed to accumulate at laser-induced damage tracks, and siRNA depletion of XRCC1 and/or XRCC4 reduced PNKP accumulation. Cells expressing the FHA mutant showed increased sensitivity to ionizing radiation, delayed SSB and DSB repair, and genome instability (micronuclei, chromosome bridges).\",\n      \"method\": \"Laser micro-irradiation with live-cell confocal imaging, siRNA knockdown of XRCC1/XRCC4, PNKP FHA domain point mutants, clonogenic survival, comet assay, γH2AX foci, micronuclei/chromosome bridge scoring\",\n      \"journal\": \"Mutation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (imaging, knockdown, mutagenesis, repair assays, cytogenetics) in a single study\",\n      \"pmids\": [\"33220551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"A conserved glutamine mutation in PNKP causing AOA4 does not significantly reduce enzymatic activities in vitro, but severely abrogates nuclear localization of PNKP. The mutant PNKP fails to interact with importin alpha (but not importin beta), blocking nuclear import. Western blot of AOA4 patient PBMCs confirmed cytoplasmic retention of mutant PNKP. Cells expressing mutant PNKP accumulate DNA double-strand breaks and activate DNA damage response pathways despite normal enzymatic activity.\",\n      \"method\": \"In vitro enzymatic activity assays, immunofluorescence for subcellular localization, co-immunoprecipitation with importin alpha/beta, Western blotting of patient-derived PBMCs, γH2AX assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods linking localization defect to interaction loss and functional consequence, validated in patient cells\",\n      \"pmids\": [\"37061005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PNKP interacts with the nuclear isoform of PFKFB3, and PFKFB3's product fructose-2,6-bisphosphate (F2,6BP) acts as a cofactor that is required for PNKP activity. PFKFB3 depletion markedly abrogates PNKP activity without changing its protein level. F2,6BP levels are significantly lower in nuclear extracts from postmortem HD and SCA3 patient brains; supplementation of F2,6BP restored PNKP activity in these extracts and rescued genome integrity and HD phenotypes in Drosophila.\",\n      \"method\": \"Co-immunoprecipitation of PNKP with PFKFB3, PNKP activity assays with/without F2,6BP supplementation in nuclear extracts, PFKFB3 siRNA depletion, rescue in Drosophila HD model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — biochemical reconstitution of cofactor dependence, patient brain tissue validation, and in vivo rescue in Drosophila\",\n      \"pmids\": [\"39298485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PNKP participates in DNA replication by functioning at replication forks, associating with PCNA, and contributing to Okazaki fragment (OF) maturation. CDK1/2 phosphorylate PNKP at multiple residues; mutation of these phosphorylation sites impairs PNKP function in DNA replication. Cellular depletion of PNKP produces defects similar to those of other OFM-related proteins.\",\n      \"method\": \"iPOND/replication fork enrichment, co-immunoprecipitation with PCNA, CDK1/2 kinase assays with PNKP, phosphorylation site mutagenesis, replication fork dynamics assays after PNKP depletion\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays in single lab; replication fork localization and PCNA interaction established\",\n      \"pmids\": [\"39395804\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CDK-mediated phosphorylation of PNKP at threonine 118 (T118) is required for PNKP recruitment to ssDNA gaps between Okazaki fragments during DNA replication. T118A-expressing cells accumulate ssDNA gaps in S phase and show accelerated replication fork progression. PNKP is involved in PARP1-dependent replication gap filling as a backup pathway when OF ligation is impaired.\",\n      \"method\": \"T118A phospho-site mutagenesis, ssDNA gap detection in S phase, replication fork progression assays (DNA fiber analysis), PARP1-dependent gap filling assay\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — phospho-site mutagenesis with multiple orthogonal replication assays defining mechanism at Okazaki fragments\",\n      \"pmids\": [\"40146629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PNKP localizes at stalled replication forks and protects them from nucleolytic degradation of nascent DNA. Loss of PNKP leads to TOP1-dependent nascent DNA degradation at stalled forks (distinct from the BRCA2-dependent pathway). Hydroxyurea treatment causes ribonucleotide misincorporation that traps TOP1 at stalled forks; reducing TOP1 or TDP1 reverses nascent DNA degradation in PNKP-deficient cells.\",\n      \"method\": \"iPOND for fork localization, DNA fiber analysis for nascent strand degradation, epistasis with BRCA2, TDP1 and TOP1 knockdown rescue experiments\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct fork localization, genetic epistasis, mechanistic pathway placement with multiple rescue experiments\",\n      \"pmids\": [\"39671289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structure of the NHEJ short-range synaptic complex shows Pol λ and PNKP simultaneously bound to the complex, demonstrating that NHEJ can form large multifunctional end-processing complexes. The structure reveals the mode of Pol λ recruitment and establishes coordinated end-processing by both factors at the short-range synaptic complex.\",\n      \"method\": \"Cryo-EM structure determination of NHEJ short-range synaptic complex with Pol λ and PNKP\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — cryo-EM structure is Tier 1, but preprint and limited functional validation reported in abstract\",\n      \"pmids\": [\"40501590\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ZIKV infection relocalizes PNKP from the nucleus to the cytoplasm in neural progenitor cells (NPC), colocalizing with ZIKV replication factory marker NS1, causing functional nuclear PNKP depletion and DNA damage accumulation. Two PNKP phosphatase inhibitors or PNKP knockout inhibited ZIKV replication, indicating PNKP is a host factor required for ZIKV replication.\",\n      \"method\": \"Immunofluorescence colocalization of PNKP with NS1 in infected NPC, PNKP inhibitors and PNKP knockout to assess ZIKV replication, γH2AX for DNA damage, Chk1/Chk2 activation assays\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiments combined with genetic (KO) and pharmacological functional validation in two orthogonal approaches\",\n      \"pmids\": [\"35412344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In atherosclerosis, macrophage-derived exosomal miR-146a-5p suppresses PNKP expression; reduced PNKP decreases its interaction with DDOST, leading to enhanced DDOST phosphorylation and activation of JAGN1-dependent NET formation in neutrophils.\",\n      \"method\": \"Co-immunoprecipitation of PNKP with DDOST, Western blot, qRT-PCR, dual-luciferase reporter, RIP assay in ApoE-/- mouse model and ox-LDL-stimulated macrophages\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP establishes interaction, but mechanism is single-lab and involves non-canonical PNKP function outside DNA repair\",\n      \"pmids\": [\"41109654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PNKP is acetylated at two lysine residues in different domains: K142 is constitutively acetylated by p300, while K226 is acetylated by CBP only after DSB induction. AcK142-PNKP associates exclusively with BER/SSBR proteins and AcK226-PNKP exclusively with DSBR proteins. Cells expressing non-acetylable K142R or K226R PNKP accumulate DNA damage specifically in transcribed genes. In HD striatal neuronal cells, K142 but not K226 was acetylated, consistent with CBP degradation in HD.\",\n      \"method\": \"Site-specific acetylation identification, Co-IP with acetylation-specific antibodies, p300/CBP knockdown/identification as acetyltransferases, non-acetylable mutant cell lines, γH2AX assay, chromatin-immunoprecipitation with Ac-PNKP antibodies\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods identifying writers and functional consequences; preprint status lowers confidence\",\n      \"pmids\": [\"37645927\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HTT organizes a mitochondrial DNA repair complex containing HTT, mitochondrial RNA polymerase, transcription factors, and PNKP. Mutant HTT impairs this complex causing persistent mitochondrial DNA lesions. Restoring PNKP expression in a Drosophila HD model improves mitochondrial genome integrity and ameliorates motor deficits.\",\n      \"method\": \"Co-immunoprecipitation of mitochondrial repair complex components, mitochondrial DNA damage assays, PNKP overexpression rescue in Drosophila HD model\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — Co-IP and genetic rescue in Drosophila; preprint, single lab, limited validation\",\n      \"pmids\": [\"bio_10.1101_2025.07.24.666629\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PNKP is present in mitochondria and its activity is decreased in mitochondrial extracts from HD patient brains due to reduced PFKFB3 and F2,6BP levels. PFKFB3 is part of a mitochondrial DNA repair complex containing HTT, PNKP, DNA Pol γ (POLG), and Lig IIIα. PNKP binds F2,6BP with Kd ~525 nM. Addition of F2,6BP restored PNKP activity in HD mitochondrial extracts and restored mitochondrial genome integrity in HD cells and Drosophila.\",\n      \"method\": \"Subcellular fractionation and PNKP activity assay in mitochondrial extracts, Co-IP of mitochondrial repair complex, F2,6BP binding assay (Kd measurement), F2,6BP supplementation rescue in HD cells and Drosophila\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Weak — biochemical binding assay and mitochondrial localization with complex purification; preprint, single lab\",\n      \"pmids\": [\"bio_10.1101_2024.11.04.621834\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HTT coordinates a Transcription-Coupled NHEJ (TC-NHEJ) complex containing PNKP, Ku70/80, XRCC4, and chromatin remodeler BRG1 to resolve transcription-associated DSBs in brain. HTT recruitment to DSBs in transcriptionally active gene-rich regions is BRG1-dependent, while efficient recruitment of TC-NHEJ proteins including PNKP is HTT-dependent. PNKP overexpression in a Drosophila HD model restores TC-NHEJ, improving genome integrity, motor defects, and lifespan.\",\n      \"method\": \"Co-immunoprecipitation of TC-NHEJ complex, ChIP at DSBs, BRG1/HTT dependency assays by knockdown, PNKP overexpression in Drosophila HD model rescue\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal biochemical and genetic experiments, preprint status limits confidence\",\n      \"pmids\": [\"bio_10.1101_2024.09.19.613927\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PNKP targeting in TNBC activates ferroptosis through the autophagic machinery. PNKP and STAT3 are rapidly phosphorylated, colocalize, and interact upon ferroptosis induction or doxorubicin treatment. PNKP inhibition activates STING and inhibits STAT3, increasing ferritinophagy and intracellular iron levels while decreasing GPX4 and SCD1. PNKP inhibition synergized with doxorubicin in TNBC animal models and patient-derived organoids.\",\n      \"method\": \"Co-immunoprecipitation of PNKP with STAT3, immunofluorescence colocalization, transcriptomic profiling, ferroptosis markers (ROS, glutathione, SCD1, GPX4), animal model and organoid therapeutic experiments\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP and colocalization with functional mechanistic pathway data; novel non-canonical PNKP function, single lab\",\n      \"pmids\": [\"40743845\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PNKP is a bifunctional nuclear (and mitochondrial) DNA repair enzyme with DNA 3'-phosphatase and DNA 5'-kinase activities that processes damaged DNA termini in multiple repair pathways (BER, SSBR, NHEJ, TCR, and Okazaki fragment maturation); it is recruited to single-strand breaks via a bipartite interaction between its FHA domain and XRCC1 (phosphorylated by CK2), is recruited to NHEJ via XRCC4-LigIV interaction, is stabilized by ATM-mediated phosphorylation at S114/S126 that prevents Cul4A-DDB1-STRAP-mediated proteasomal degradation, has its activity allosterically modulated by F2,6BP (produced by PFKFB3), is regulated by CDK1/2-mediated phosphorylation at T118 for Okazaki fragment gap filling, is site-specifically acetylated by p300 (K142, directing BER/SSBR) and CBP (K226, directing DSBR) to partition it between repair pathways, and forms transcription-coupled repair complexes with HTT/POLR2A/ATXN3/CBP whose functional integrity is disrupted by polyglutamine-expanded proteins in HD and SCA3.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PNKP is a bifunctional DNA repair enzyme that processes damaged DNA termini through its DNA 5'-kinase and 3'-phosphatase activities, generating ligatable ends required across single-strand break repair (SSBR), non-homologous end joining (NHEJ), and DNA replication [#0, #10]. It is recruited to single-strand breaks through a bipartite mechanism in which its FHA domain (notably Arg35/Arg48) binds CK2-phosphorylated XRCC1 with high affinity to tether the proteins, while a second low-affinity contact through the XRCC1 RIR motif stimulates PNKP kinase activity; PARP1/PARP2-dependent ADP-ribosylation underpins this recruitment to oxidative breaks [#3, #4, #5, #9, #11]. In NHEJ, the same FHA domain and a phosphatase-domain surface engage CK2-phosphorylated XRCC4-LigIV, positioning PNKP within multifunctional end-processing synaptic complexes [#3, #11]. PNKP abundance and localization are tightly regulated: ATM-mediated phosphorylation at S114/S126 blocks Cul4A-DDB1-STRAP-dependent proteasomal degradation, importin-alpha mediates its nuclear import, and PFKFB3-derived fructose-2,6-bisphosphate acts as a required cofactor for its catalytic activity [#2, #12, #13]. PNKP also functions at replication forks, where CDK1/2 phosphorylation (including at T118) directs it to ssDNA gaps for Okazaki fragment maturation and PARP1-dependent backup gap filling, and where it protects stalled forks from TOP1-dependent nascent DNA degradation [#14, #15, #16]. Loss of PNKP function causes human disease: distinct mutations underlie MCSZ, AOA4, and CMT2B2, with reduced phosphatase activity correlating with neurodevelopmental dysfunction and reduced kinase activity with neurodegeneration [#1, #10, #12]. PNKP integrity is also compromised in polyglutamine disorders, where mutant ATXN3 and HTT impair PNKP within transcription-coupled repair complexes, driving DNA break accumulation and aberrant ATM signaling [#6, #7].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established the core biochemical identity of PNKP as a single enzyme carrying two distinct DNA-end-processing activities, defining its fundamental role in restoring repair-competent termini.\",\n      \"evidence\": \"GST-PNKP in vitro kinase/phosphatase assays plus E. coli xth nfo complementation\",\n      \"pmids\": [\"10446192\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define recruitment partners or pathway context in mammalian cells\", \"No structural basis for substrate selection\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linked PNKP enzymatic and stability defects to human disease, showing that disease mutations reduce kinase/phosphatase activity, lower protein levels, and impair cellular strand break repair.\",\n      \"evidence\": \"Recombinant mutant enzyme assays, Western blotting, and strand break repair assays in MCSZ patient cells\",\n      \"pmids\": [\"22508754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking specific activity loss to neuronal phenotype not resolved here\", \"Did not distinguish SSBR vs DSBR contributions\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined how PNKP abundance is controlled by a damage-responsive switch, showing ATM phosphorylation stabilizes PNKP against Cul4A-DDB1-STRAP-mediated degradation.\",\n      \"evidence\": \"Phospho-site mapping, ubiquitylation assays, Cul4A-DDB1-STRAP purification, Strap-/- MEFs\",\n      \"pmids\": [\"23042680\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and kinetics of the stabilization switch not quantified\", \"Whether other kinases contribute is unaddressed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Connected PNKP dysfunction to polyglutamine neurodegeneration, showing mutant ATXN3 binds and inactivates PNKP upstream of ATM-p53-PKCδ apoptotic signaling.\",\n      \"evidence\": \"Co-IP, PNKP activity assays, ATM-inhibitor and PNKP-overexpression rescue in SCA3 cell and mouse models\",\n      \"pmids\": [\"25590633\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of mutant ATXN3-mediated inactivation undefined\", \"Generalizability to other polyQ proteins not yet shown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved how PNKP is integrated into both NHEJ and SSBR through FHA-domain interactions with phosphorylated XRCC4-LigIV and XRCC1, and established a bipartite tethering/stimulation model.\",\n      \"evidence\": \"SAXS, HDX-MS, recombinant complex assays, RIR mutagenesis, and laser-microirradiation recruitment in human cells\",\n      \"pmids\": [\"28453785\", \"28821613\", \"29100039\", \"27965414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"High-resolution structure of full complexes not obtained\", \"Quantitative contribution of each interaction in vivo not fully partitioned\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended the XRCC1-PNKP interaction beyond the canonical phospho-segment and tied common XRCC1 SNPs to reduced PNKP recruitment and stimulation.\",\n      \"evidence\": \"Biochemical binding/activity assays with XRCC1 fragments and SNP variants plus laser-microirradiation recruitment\",\n      \"pmids\": [\"30446622\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of the extended interaction not determined\", \"Physiological impact of SNPs at organismal level unaddressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Placed PNKP within an HTT-organized transcription-coupled repair complex, showing mutant HTT impairs PNKP and causes break accumulation in transcribed genes.\",\n      \"evidence\": \"Co-IP of HTT/POLR2A/ATXN3/PNKP/CBP complex, activity assays, and PNKP rescue in HD cell and mouse models\",\n      \"pmids\": [\"30994454\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise architecture of the TCR complex unresolved\", \"How transcription couples to PNKP loading not mechanistically defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Mapped genotype-to-pathway relationships across PNKP-linked diseases and proved an essential role for the FHA domain in recruitment and genome stability.\",\n      \"evidence\": \"Comet/γH2AX repair assays in patient fibroblasts with domain-specific complementation, plus FHA point mutants and XRCC1/XRCC4 depletion with cytogenetic readouts\",\n      \"pmids\": [\"32504494\", \"33220551\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why phosphatase loss preferentially drives neurodevelopmental vs kinase loss neurodegenerative phenotypes not mechanistically explained\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed that subcellular localization, not catalysis, is the defect in AOA4, establishing importin-alpha-dependent nuclear import as essential for PNKP function.\",\n      \"evidence\": \"In vitro activity assays, immunofluorescence, importin alpha/beta Co-IP, and patient PBMC Western blots\",\n      \"pmids\": [\"37061005\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nuclear localization signal not precisely mapped\", \"Whether import is regulated dynamically during the cell cycle unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified a metabolic cofactor requirement for PNKP, showing PFKFB3-derived fructose-2,6-bisphosphate is needed for activity and is deficient in polyQ disease brains.\",\n      \"evidence\": \"PFKFB3 Co-IP, F2,6BP supplementation and depletion in nuclear/mitochondrial extracts, Kd measurement, and Drosophila HD rescue\",\n      \"pmids\": [\"39298485\", \"bio_10.1101_2024.11.04.621834\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Allosteric mechanism by which F2,6BP modulates catalysis not structurally defined\", \"Whether cofactor levels are dynamically regulated under stress unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a replication-associated role for PNKP at forks, including Okazaki fragment maturation, PCNA association, and protection of stalled forks from TOP1-dependent degradation.\",\n      \"evidence\": \"iPOND, PCNA Co-IP, CDK1/2 kinase and phospho-site assays, DNA fiber analysis, and TOP1/TDP1 epistasis\",\n      \"pmids\": [\"39395804\", \"39671289\", \"40146629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative importance of replicative vs repair functions in tissues not weighed\", \"Coordination between fork-protection and gap-filling roles undefined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Proposed acetylation as a pathway-partitioning code, with p300-mediated K142 directing BER/SSBR and CBP-mediated K226 directing DSBR.\",\n      \"evidence\": \"Site-specific acetylation mapping, acetyl-specific Co-IP and ChIP, p300/CBP knockdown, and non-acetylable mutant cells (preprint)\",\n      \"pmids\": [\"37645927\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint status; awaits peer-reviewed confirmation\", \"How acetylation switches partner selection mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended PNKP's repair role to NHEJ synaptic architecture and to mitochondrial and transcription-coupled NHEJ complexes, while uncovering non-canonical roles in ZIKV replication, atherosclerosis, and TNBC ferroptosis.\",\n      \"evidence\": \"Cryo-EM of NHEJ synaptic complex with Pol λ and PNKP (preprint), Co-IP of TC-NHEJ and mitochondrial repair complexes (preprints), and Co-IP/functional assays for DDOST, STAT3, and ZIKV NS1 interactions\",\n      \"pmids\": [\"40501590\", \"bio_10.1101_2024.09.19.613927\", \"bio_10.1101_2025.07.24.666629\", \"35412344\", \"41109654\", \"40743845\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Several findings are preprints or single-lab studies\", \"Non-canonical PNKP functions outside DNA repair are not mechanistically integrated with its enzymatic activity\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PNKP's multiple regulatory layers — phosphorylation, acetylation, nuclear import, and metabolic cofactor supply — are integrated to partition the single enzyme among SSBR, NHEJ, replication, and mitochondrial repair in different cell types remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model of regulated pathway selection\", \"Tissue-specific determinants of PNKP function in neurons vs proliferating cells unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 1, 10]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 10]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 10]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [12, 18]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [21, 22]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [11, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0, 3, 10, 11]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [14, 15, 16]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 6, 7, 10, 12]}\n    ],\n    \"complexes\": [\n      \"XRCC4-LigIV NHEJ complex\",\n      \"NHEJ short-range synaptic complex\",\n      \"HTT/POLR2A/ATXN3/PNKP/CBP transcription-coupled repair complex\",\n      \"HTT mitochondrial DNA repair complex\"\n    ],\n    \"partners\": [\n      \"XRCC1\",\n      \"XRCC4\",\n      \"LIG4\",\n      \"PCNA\",\n      \"PFKFB3\",\n      \"ATXN3\",\n      \"HTT\",\n      \"POLR2A\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}